Stay updated on ASN002 in Chronic Hand Eczema Clinical Trial
Sign up to get notified when there's something new on the ASN002 in Chronic Hand Eczema Clinical Trial page.

Latest updates to the ASN002 in Chronic Hand Eczema Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record for the Phase 2 ASN002 study in chronic hand eczema is displayed, with details on its design, eligibility, participating locations, and outcome measures.SummaryDifference58%

- Check8 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check29 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 on an otherwise unchanged 403 Forbidden page.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating that access to the trial details is blocked and the usual information is not visible.SummaryDifference18%

Stay in the know with updates to ASN002 in Chronic Hand Eczema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASN002 in Chronic Hand Eczema Clinical Trial page.